The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6697936 7366963 I 6697936-8 20100314 20100420 20100427 PER US-BIOGENIDEC-2010BI013574 BIOGEN IDEC INC. 34 YR F Y 20100427 CN UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6697936 1013573613 PS TYSABRI 1 INTRAVENOUS
6697936 1013573614 C AVONEX 1 INTRAMUSCULAR

Indications of drugs used

Event ID DRUG SEQ INDI PT
6697936 1013573613 MULTIPLE SCLEROSIS
6697936 1013573614 MULTIPLE SCLEROSIS

Outcome of event

no results found

Reactions reported

Event ID PT
6697936 BALANCE DISORDER
6697936 GAIT DISTURBANCE
6697936 HYPOAESTHESIA
6697936 MUSCLE SPASTICITY
6697936 VISUAL IMPAIRMENT

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6697936 1013573613 20080314 20100226
6697936 1013573614 20000419